Berger Montague is proud to announce that Thomson Reuters has named 25 of our attorneys part of the 2023 Super Lawyers and Rising Stars list. Here is a complete list of the award-winning attorneys and their respective practice areas: Antitrust: Coslett, Caitlin G.Cramer, Eric L.Davidoff, Merrill G.,Sorensen, David F.Twersky, Martin […]
Berger Montague is now powered by 89 attorneys across seven offices in the United States and Canada, having experienced considerable growth in 2023. Philadelphia, PA / May 23, 2023 / Adding to its premier capabilities, Berger Montague, a complex litigation powerhouse, is pleased to announce the addition of eight new trial lawyers […]
Berger Montague is proud to announce that the Firm and its lawyers have been honored with five Legal Intelligencer Professional Excellence Awards. The Firm is also a finalist for Law Firm of the Year.
(April 13, 2023). The Ontario Superior Court of Justice, Honourable E.M. Morgan, issued a direction that he will refrain from further motion practice so the representative investors in the 4 Canadian class actions can prepare to resolve all the claims on behalf of all investors that purchased Wayland Group Corp.’s securities in […]
(March 8, 2023) On behalf of shareholders, Class Counsel have been successful in reaching a Discovery Plan with Auxly Cannabis Group Inc. (“Auxly”) whereby it will turn over internal documents and emails of Chuck Rifici, Hugo Alves, and other insiders. Previously, FSD Pharma, Inc. produced hundreds of pages of internal documents […]
Berger Montague is expanding internationally with the opening of an office in Toronto. Berger Montague Canada will be a full-service civil litigation, class action, and commercial litigation law firm with a particular focus on securities and antitrust litigation.
Berger Montague PC has filed a class action lawsuit on behalf of investors who purchased securities of Medical Properties Trust, Inc. (NYSE: MPW) from July 15, 2019 through and including February 22, 2023.
Berger Montague is investigating Boston Scientific Corporation's Board of Directors for potential breaches of fiduciary duties to the Company and its shareholders.
Berger Montague is currently investigating potential violations of the federal securities laws on behalf of shareholders of Ascendis Pharma A/S (NASDAQ: ASND).
Berger Montague is pleased to share that on March 16, 2023, the United States District Court for the Southern District of New York denied Cloopen Group Holding’s motion to dismiss Plaintiffs’ claims in a securities fraud class action lawsuit. Berger Montague serves as Lead Counsel.
Berger Montague and Kleiman/Rajaram announce that they have achieved a $28 million settlement in the qui tam litigation brought against Santa Barbara County and its Behavioral Wellness Agency over allegations of Medicaid fraud.
Berger Montague announces the opening of new offices in San Francisco and Chicago. Shareholder Joshua Davis manages the San Francisco office, and Senior Counsel Richard Schwartz manages the Chicago office.